Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06146335 · ClinicalTrials.gov registry record · NA
Analysis of Biologic Signatures in Crohn's Patients Undergoing Surgery
A NA study of Crohn Disease, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT06146335: Completed NA study of Crohn Disease, sponsored by Weill Medical College of Cornell University.
NCT06146335 is a NA study of Crohn Disease that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 11 participants, below the 205-participant average among 71 other Crohn Disease trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06146335, a NA study of Crohn Disease, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the effect of two procedures - the Kono-S procedure and the side-to-side functional end to end anastomosis - on the microbiome (the bacteria that live in our gut) and on the intestinal immune system. The investigators are hypothesizing that there are differences in the microbiome environment and the immune environment between the two procedural groups.
Primary Outcome
Microbiome composition will be measured via an analysis of of 16S rRNA sequencing from tissue samples.
Conditions Studied
Interventions
- PROCEDURE Kono-S anastomosis (KSa)
- PROCEDURE Side-to-side anastomosis (SSa)
Study Locations (1)
New York
- Weill Cornell Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2024-01-03 |
| Est. Completion | 2025-05-31 |
| Phase | NA |
What the finished NCT06146335 record still lists
NCT06146335 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 205-participant average among 71 other Crohn Disease trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Crohn Disease appearing as the primary indexed condition, and to 2 interventions - of which Kono-S anastomosis (KSa) is the first listed.
NCT06146335 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06146335 about?
NCT06146335 is a clinical study titled "Analysis of Biologic Signatures in Crohn's Patients Undergoing Surgery". The purpose of this study is to compare the effect of two procedures - the Kono-S procedure and the side-to-side functional end to end anastomosis - on the microbiome (the bacteria that live in our gut) and on the intestinal immune system. The investigators are hypothesizing that there are differenc...
What is the current status of trial NCT06146335?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2024-01-03. Estimated completion is 2025-05-31.
What conditions does trial NCT06146335 study?
This clinical trial studies the following conditions: Crohn Disease.
What interventions are being tested in trial NCT06146335?
The interventions under investigation include: Kono-S anastomosis (KSa) (PROCEDURE), Side-to-side anastomosis (SSa) (PROCEDURE).
Who is sponsoring clinical trial NCT06146335?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06146335 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Crohn Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06146335's enrollment target sits among peer trials
11 69th of 71 higher than 3 of 71 other Crohn Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Crohn Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
RECRUITING · NA
-
Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
RECRUITING · NA
-
Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility
RECRUITING · NA
-
Impact of Prebiotics in Ulcerative Colitis
RECRUITING · NA
-
RISE: A Remote Study of Insomnia Treatment in Crohn's Disease
RECRUITING · NA
-
A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI